Cet anticorps anti- est un anticorps Lapin Polyclonal détectant dans IHC et WB. Adapté pour Humain, Souris, Rat, Poulet, Boeuf (Vache) et Xenopus laevis.
N° du produit ABIN5688908
Aperçu rapide pour GABA B Receptor (pSer783) anticorps (ABIN5688908)
Antigène
GABA B Receptor
Reactivité
Humain, Souris, Rat, Poulet, Boeuf (Vache), Xenopus laevis
Hôte
Lapin
Clonalité
Polyclonal
Conjugué
Inconjugué
Application
Immunohistochemistry (IHC), Western Blotting (WB)
Épitope
pSer783
Purification
Affinity Purified
Immunogène
Phosphopeptide corresponding to amino acid residues surrounding the phospho-Ser783 of GABAB R2.
Reactivité: Humain, Souris, Rat
Hôte: Lapin
Polyclonal
Alexa Fluor 594
Indications d'application
The antibody has been directly tested for reactivity in Western blots with rat tissue. It is anticipated that the antibody will react with mouse, human, non-human primate, chicken, bovine and Xenopus tissues based on the fact that these species have 100 % homology with the amino acid sequence used as antigen.
Restrictions
For Research Use only
Format
Liquid
Buffer
100 μLin 10 mM HEPES ( pH 7.5), 150 mM NaCl, 100 μg per mL BSA and 50 % glycerol.
Stock
-20 °C
Stockage commentaire
GABAB Receptor antibody can be stored at -20°C and is stable at -20°C for at least 1 year.
Antigène
GABA B Receptor
Autre désignation
GABAB Receptor
Sujet
Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the central nervous system. There are two major classes of GABA receptors: the GABAA and the GABAB subtype of receptors. GABAB receptors are heterodimeric G protein-coupled receptors that mediate slow synaptic inhibition in the central nervous system. It has recently been demonstrated that AMPK binds directly to GABAB receptors and phosphorylates S783 in the cytoplasmic tail of the R2 subunit and that S783 plays a critical role in enhancing neuronal survival after ischemia as phosphorylation of S783 is evident in many brain regions and is increased dramatically after ischemic injury to the brain (Kuramoto et al., 2007).